Sheng-Nan Lu Selected Research

Liver Diseases (Liver Disease)

5/2024	Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver disease.
2/2024	Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
10/2022	Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care.
2/2022	Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
1/2020	Real-world experience of elbasvir/grazoprevir in Taiwan: This study was focused on liver and renal adverse effects.
1/2019	Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening.
8/2014	Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.
9/2013	Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.
8/2013	Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
6/2013	Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversion.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheng-Nan Lu Research Topics

Disease

96	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 07/2002
81	Fibrosis (Cirrhosis) 02/2024 - 03/2002
69	Chronic Hepatitis B 02/2024 - 01/2002
69	Infections 02/2024 - 01/2002
45	Chronic Hepatitis C 01/2023 - 12/2002
32	Neoplasms (Cancer) 05/2024 - 02/2002
27	Hepatitis B 01/2024 - 01/2002
22	Hepatitis C 01/2024 - 03/2002
17	Liver Diseases (Liver Disease) 05/2024 - 07/2005
17	Liver Cirrhosis (Hepatic Cirrhosis) 04/2021 - 03/2002
13	Hepatitis 08/2022 - 01/2002
10	Liver Neoplasms (Liver Cancer) 06/2023 - 05/2004
9	Viremia 01/2024 - 03/2003
6	Thrombosis (Thrombus) 05/2024 - 01/2009
6	Diabetes Mellitus 06/2023 - 05/2011
6	Disease Progression 01/2021 - 10/2014
5	Neoplasm Metastasis (Metastasis) 05/2024 - 03/2007
5	Chronic Kidney Failure (Chronic Renal Failure) 06/2023 - 01/2017
5	Inflammation (Inflammations) 10/2019 - 03/2004
5	Hemorrhage 07/2017 - 09/2011
5	Persistent Infection 06/2011 - 05/2005
4	Hypertension (High Blood Pressure) 01/2023 - 01/2015
4	Virus Diseases (Viral Diseases) 01/2019 - 05/2003
4	End Stage Liver Disease 06/2017 - 01/2014
4	Thrombocytopenia (Thrombopenia) 06/2014 - 11/2006
4	Peptic Ulcer (Peptic Ulcers) 01/2014 - 09/2003
3	Body Weight (Weight, Body) 01/2024 - 11/2006
3	Varicose Veins (Varicose Vein) 04/2021 - 10/2014
3	Ascites 01/2015 - 03/2009
3	Hepatic Encephalopathy 01/2015 - 07/2005
3	Overweight 11/2012 - 11/2008
3	Necrosis 03/2010 - 03/2008
2	Acute-On-Chronic Liver Failure 01/2024 - 06/2014
2	Anemia 01/2020 - 11/2006
2	Chronic Renal Insufficiency 01/2020 - 07/2017
2	Liver Failure 01/2018 - 07/2005
2	Alcoholism (Alcohol Abuse) 04/2015 - 01/2014
2	Fatty Liver 08/2014 - 01/2013
2	Chronic Hepatitis (Chronic Active Hepatitis) 08/2014 - 05/2010

Drug/Important Bio-Agent (IBA)

57	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2024 - 01/2002
44	Hepatitis B e AntigensIBA 02/2024 - 07/2002
44	Antiviral Agents (Antivirals)IBA 02/2024 - 10/2005
37	entecavir FDA Link 01/2024 - 03/2012
29	InterferonsIBA 12/2020 - 12/2002
29	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 12/2002
26	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 04/2004
25	Alanine Transaminase (SGPT)IBA 02/2022 - 03/2002
22	Tenofovir (Viread)FDA Link 01/2023 - 01/2015
20	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 03/2002
15	RNA (Ribonucleic Acid)IBA 08/2020 - 05/2003
14	AlbuminsIBA 06/2023 - 10/2007
14	Lamivudine (Epivir)FDA Link 12/2017 - 01/2002
12	Sorafenib (BAY 43-9006)FDA Link 05/2024 - 06/2013
12	AntigensIBA 01/2023 - 11/2008
11	BilirubinIBA 06/2023 - 07/2005
11	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2022 - 03/2009
8	Surface Antigens (Surface Antigen)IBA 11/2020 - 07/2012
7	Fetal Proteins (Fetoprotein)IBA 01/2020 - 03/2009
6	Transaminases (Aminotransferases)IBA 04/2021 - 08/2004
5	EnzymesIBA 05/2024 - 05/2005
5	peginterferon alfa-2a (Pegasys)FDA Link 12/2020 - 02/2009
4	glecaprevir and pibrentasvirIBA 01/2022 - 01/2020
4	Messenger RNA (mRNA)IBA 12/2021 - 05/2004
4	lipoarabinomannan (LAM)IBA 06/2014 - 01/2010
4	adefovirIBA 02/2011 - 07/2005
4	Ethanol (Ethyl Alcohol)IBA 03/2010 - 05/2006
3	VaccinesIBA 10/2022 - 12/2005
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2010
3	SofosbuvirIBA 10/2021 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 09/2011
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 11/2006
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	Aflatoxin B1 (Aflatoxin B)IBA 01/2018 - 04/2015
3	CytokinesIBA 06/2016 - 08/2009
3	AntibodiesIBA 10/2014 - 07/2002
3	AdiponectinIBA 08/2014 - 08/2009
3	Interferon-alpha (Interferon Alfa)IBA 03/2014 - 03/2003
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 12/2007
2	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 01/2014
2	AcidsIBA 10/2021 - 09/2003
2	velpatasvirIBA 10/2021 - 06/2021
2	lenvatinibIBA 01/2021 - 01/2021
2	dasabuvirIBA 01/2019 - 01/2019
2	ombitasvirIBA 01/2019 - 01/2019
2	paritaprevirIBA 01/2019 - 01/2019
2	Ritonavir (Norvir)FDA Link 01/2019 - 01/2019
2	Telbivudine FDA Link 07/2017 - 03/2012
2	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2016 - 08/2014
2	ORALIT (ORS)IBA 01/2016 - 07/2010
2	ProteomeIBA 07/2015 - 01/2008
2	InterleukinsIBA 05/2015 - 08/2009

Therapy/Procedure

83	Therapeutics 01/2024 - 01/2002
13	Radiofrequency Ablation 06/2023 - 03/2010
7	Drug Therapy (Chemotherapy) 01/2024 - 01/2002
7	Aftercare (After-Treatment) 01/2020 - 02/2009
6	Liver Transplantation 01/2020 - 09/2013
5	Retreatment 01/2024 - 01/2019
4	Antibiotic Prophylaxis 01/2014 - 09/2011
3	Radiotherapy 06/2022 - 02/2002
2	Surgical Instruments (Clip) 06/2023 - 01/2009